{"id":17437,"date":"2023-12-11T14:37:36","date_gmt":"2023-12-11T13:37:36","guid":{"rendered":"https:\/\/www.cirff.it\/?page_id=17437"},"modified":"2023-12-20T16:40:33","modified_gmt":"2023-12-20T15:40:33","slug":"pubblicazioni-2","status":"publish","type":"page","link":"https:\/\/www.cirff.it\/?page_id=17437","title":{"rendered":"Articoli Scientifici"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t
\n\t\t\t\n\t\n<\/svg>\t\t<\/div>\n\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t

Articoli Scientifici<\/h1>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t

2023<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
  1. Drug Utilization and Measurament of Medication Adherence: A Real World Study of Psoriasis in Italy. <\/strong><\/a>Pharmaceutics<\/em><\/li>
  2. Longitudinal Trajectory Modeling to Assess Adherence to Sacubitril\/Valsartan among Patients with Heart Failure. <\/strong><\/a>Pharmaceutics<\/em><\/li>
  3. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA.<\/strong><\/a>\u00a0Journal of Nutrition, Health and Aging<\/em><\/li>
  4. Drug Repurposing in Oncology: A Systematic Review of Randomized Controlled Clinical Trials. <\/strong><\/a>Cancers<\/em><\/li>
  5. Italian Translation and Validation of the Original ABC Taxonomy for Medication Adherence.<\/strong><\/a>\u00a0Healthcare\u00a0<\/em><\/li>
  6. Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air\u00ae approach. <\/strong><\/a>Clinical and Translational Allergy<\/em><\/li><\/ol><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t2022<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
    1. Management of allergic rhinitis symptoms in the pharmacy Pocket guide 2022<\/strong>.<\/a> Clinical and Translational Allergy <\/em><\/li>
    2. Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: Data from the Campania Rare Diseas
      e Registry.<\/strong><\/a> Journal of Public Health\u00a0<\/em><\/li>
    3. Developing and piloting a communication assessment tool assessing patient perspectives on communication with pharmacists (CAT-Pharm).<\/strong><\/a> International Journal of Clinical Pharmacy <\/em><\/li>
    4. Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study.<\/strong><\/a>\u00a0Frontiers in Pharmacology<\/em><\/li>
    5. Adaptation of communication assessment tool for community pharmacists in medication adherence and minor diseases management. <\/strong><\/a>Pharmacia<\/em><\/li>
    6. The Effectiveness of Interventions to Evaluate and Reduce Healthcare Costs of Potentially Inappropriate Prescriptions among the Older Adults: A Systematic Review. <\/strong><\/a>International Journal of Environmental Research and Public Health<\/em><\/li>
    7. Risk of SARS-CoV-2 Infection Breakthrough among the Non-Vaccinated and Vaccinated Population in Italy: A Real-World Evidence Study Based on Big Data. <\/strong><\/a>Healthcare<\/li>
    8. Evaluation of Factors Associated With Appropriate Drug Prescription and Effectiveness of Informative and Educational Interventions\u2014The EDU.RE.DRUG Project. <\/strong><\/a>Frontiers in Pharmacology<\/li>
    9. Postvaccination SARS-CoV-2 Infections among Healthcare Professionals: A Real World Evidence Study.<\/strong><\/a>\u00a0Vaccines<\/em><\/li>
    10. Prescription Appropriateness of Drugs for Peptic Ulcer and Gastro-Esophageal Reflux Disease: Baseline Assessment in the LAPTOP-PPI Cluster Randomized Trial. <\/strong><\/a>\u00a0Frontiers in Pharmacology<\/em><\/li>
    11. Assessment of surgeon communication skills from the patient perspective: A national evaluation using the Communication Assessment Tool.<\/strong>\u00a0<\/a>Patient Education and Counseling<\/em><\/li><\/ol><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
      \n\t\t\t\t\t
      \n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t2021<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
      1. Baseline drug treatments as indicators of increased risk of COVID-19 mortality in Spain and Italy. <\/strong><\/a>International Journal of Environmental Research and Public Health<\/em><\/li>
      2. Prevalence and Factors Associated with Potential Drug-Drug Interactions in Older Community-Dwelling Adults: A Prospective Cohort Study.<\/strong><\/a> Drugs and Aging\u00a0<\/em><\/li>
      3. Pre-exposure prophylaxis with hydroxychloroquine does not prevent covid-19 nor virus related venous thromboembolism.<\/strong><\/a> Viruses\u00a0<\/em><\/li>
      4. Cost-effectiveness of treatment optimisation with biomarkers for immunotherapy in solid tumours: A systematic review protocol.<\/strong> <\/a>BMJ Open<\/em><\/li>
      5. A Cross-Sectional Survey on Medication Management Practices for Noncommunicable Diseases in Europe During the Second Wave of the COVID-19 Pandemic.<\/a> <\/strong>Frontiers in Pharmacology<\/em><\/li>
      6. Disparities in European healthcare system approaches to maintaining continuity of medication for non-communicable diseases during the COVID-19 outbreak.<\/strong><\/a> The Lancet Regional Health \u2013 Europe.<\/em><\/li>
      7. SARS\u2010CoV\u20102 in urine may predict a severe evolution of COVID\u201019.<\/strong><\/a> Journal of Clinical Medicine.<\/em><\/li>
      8. Persistence as a robust indicator of medication adherence-related quality and performance.<\/strong><\/a> International Journal of Environmental Research and Public Health.<\/em><\/li>
      9. Changes in multimorbidity and polypharmacy patterns in young and adult population over a 4-year period: A 2011\u20132015 comparison using real-world data.<\/a> <\/strong>International Journal of Environmental Research and Public Health.<\/em><\/li>
      10. Drug-utilisation Profiles and COVID-19. <\/strong><\/a>Scientific Reports.<\/em><\/li>
      11. The value of the polypill in cardiovascular disease: an Italian multidisciplinary Delphi panel consensus. <\/a><\/strong>Journal of cardiovascular medicine\u00a0<\/em><\/li>
      12. Development and validation of a clinical risk score to predict the risk of SARS-CoV-2 infection from administrative data: A population-based cohort study from Italy<\/a><\/strong>. <\/strong>PLoS ONE<\/em><\/li>
      13. ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice.<\/strong><\/a>\u00a0European Journal of Allergy and Clinical Immunology<\/em><\/li><\/ol><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
        \n\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t2020<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
          \n \t
        1. Editorial – COVID-19, more than a viral pneumonia.<\/a><\/strong> European Review for Medical and Pharmacological Sciences. <\/em><\/li>\n \t
        2. Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study.<\/a><\/strong> Clinical and Translational Allergy.<\/em><\/li>\n \t
        3. Comorbidity in an Older Population with Type-2 Diabetes Mellitus: Identification of the Characteristics and Healthcare Utilization of High-Cost Patients.<\/strong><\/a> Frontiers in Pharmacology.<\/em><\/li>\n \t
        4. Treatment patterns and medication adherence among newly diagnosed patients with migraine: A drug utilisation study.<\/strong><\/a> BMJ Open.<\/em><\/li>\n \t
        5. Economic Evaluation of Treatments for Migraine: An Assessment of the Generalizability Following a Systematic Review.<\/strong><\/a> PharmacoEconomics.<\/em><\/li>\n \t
        6. The need to develop standard measures of patient adherence for big data: Viewpoint.<\/strong><\/a> Journal of Medical Internet Research.<\/em><\/li>\n \t
        7. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air\u00ae App.<\/strong><\/a> Allergy: European Journal of Allergy and Clinical Immunology.<\/em><\/li>\n \t
        8. Gender differences in medication use: A drug utilization study based on real world data.<\/strong><\/a> International Journal of Environmental Research and Public Health.<\/em><\/li>\n \t
        9. Is diet partly responsible for differences in COVID-19 death rates between and within countries?<\/strong><\/a> Clinical and Translational Allergy. <\/em><\/li>\n \t
        10. Geographical Variation in Medication Prescriptions: A Multiregional Drug-Utilization Study.<\/strong><\/a> Frontiers in Pharmacology.<\/em><\/li>\n \t
        11. Initial therapy, regimen change, and persistence in a spanish cohort of newly treated type 2 diabetes patients: A retrospective, observational study using real-world data.<\/strong><\/a> International Journal of Environmental Research and Public Health.<\/em><\/li>\n \t
        12. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing.<\/strong><\/a> Allergy, Asthma and Immunology Research.<\/em><\/li>\n \t
        13. A pragmatic controlled trial to improve the appropriate prescription of drugs in adult outpatients: Design and rationale of the EDU.RE.DRUG study.<\/strong><\/a> Primary Health Care Research and Development.<\/em><\/li>\n \t
        14. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence.<\/strong><\/a> Journal of Allergy and Clinical Immunology.<\/em><\/li>\n \t
        15. Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19.<\/strong><\/a> Allergy: European Journal of Allergy and Clinical Immunology.<\/em><\/li>\n \t
        16. Patient centric pharmaceutical drug product design: the impact on medication adherence.<\/strong><\/a> Pharmaceutics.<\/em><\/li>\n \t
        17. Drug Utilization Pattern of Antibiotics: The Role of Age, Sex and Municipalities in Determining Variation.<\/em><\/strong><\/a> Risk Management and Healthcare Policy. <\/em><\/li>\n \t
        18. Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study.<\/strong><\/a> Multiple Sclerosis and Related Disorders.<\/em><\/li>\n \t
        19. The impact of diagnostic criteria and treatments on the 20-year costs for treating relapsing-remitting multiple sclerosis.<\/strong><\/a> Multiple Sclerosis and Related Disorders.<\/em><\/li>\n<\/ol><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
          \n\t\t\t\t\t
          \n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t2019<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
            \n \t
          1. Fixed versus free combinations of antihypertensive drugs: Analyses of real-world data of persistence with therapy in Italy.<\/a><\/strong> Patient Preference and Adherence<\/em>. <\/strong><\/li>\n \t
          2. Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study.<\/strong><\/a> Clinical and Experimental Allergy.<\/em><\/li>\n \t
          3. Patterns of multimorbidity and polypharmacy in young and adult population: Systematic associations among chronic diseases and drugs using factor analysis.<\/strong><\/a> PLoS ONE. <\/em><\/li>\n \t
          4. Treatment patterns of diabetes in Italy: A population-based study.<\/strong><\/a> Frontiers in Pharmacology. <\/em><\/li>\n \t
          5. Prescribing pattern of antihypertensive drugs in two European cohorts: a population-based database study.<\/strong><\/a> Expert Review of Pharmacoeconomics and Outcomes Research.<\/em><\/li>\n \t
          6. Adherence to treatment of hypertension, hypercholesterolaemia and diabetes in an elderly population of a Spanish cohort.<\/strong><\/a> Medicina Clinica. <\/em><\/li>\n \t
          7. 2019 ARIA Care pathways for allergen immunotherapy.<\/strong><\/a> Allergy: European Journal of Allergy and Clinical Immunology.<\/em><\/li>\n \t
          8. Analgesic drug use in elderly persons: A population-based study in Southern Italy.<\/strong><\/a> PLoS One.<\/em><\/li>\n \t
          9. ARIA pharmacy 2018 \u201cAllergic rhinitis care pathways for community pharmacy\u201d: AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Sant\u00e9).<\/strong><\/a> Allergy: European Journal of Allergy and Clinical Immunology<\/em>. 2019, 74.7: 1219-1236.<\/li>\n \t
          10. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma.<\/strong><\/a> Clinical and Translational Allergy.<\/em><\/li>\n \t
          11. Some reflections concerning the assessment of patient adherence and persistence to medication.<\/strong><\/a> Current Medical Research and Opinion<\/em>.<\/li>\n \t
          12. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study.<\/strong><\/a> Journal of Allergy and Clinical Immunology.<\/em><\/li>\n \t
          13. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology.<\/strong><\/a> Journal of Allergy and Clinical Immunology<\/em>.<\/li>\n \t
          14. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence.<\/strong><\/a> Journal of Allergy and Clinical Immunology.<\/em><\/li>\n \t
          15. Next-generation ARIA care pathways for rhinitis and asthma: A model for multimorbid chronic diseases.<\/strong><\/a> Clinical and Translational Allergy.<\/em><\/li>\n \t
          16. Impatto delle politiche farmaceutiche sull\u2019utilizzo di biosimilari: analisi di Real World Evidence<\/strong>.<\/a> Giornale Italiano di Farmacia Clinica.<\/em><\/li>\n<\/ol><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
            \n\t\t\t\t\t
            \n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t2018<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
              \n \t
            1. Are you more concerned about or relieved by medicines? <\/strong>An explorative randomized study of the impact of telephone counseling by pharmacists on patients\u2019 beliefs regarding medicines and blood pressure control.<\/strong><\/a> Patient Education and Counseling.<\/em><\/li>\n \t
            2. Predictors of new oral anticoagulant drug initiation as opposed to warfarin in elderly adults: A retrospective observational study in Southern Italy.<\/strong><\/a> Therapeutics and Clinical Risk Management.<\/em><\/li>\n \t
            3. Adherence to chronic medication in older populations: Application of a common protocol among three European cohorts.<\/strong><\/a> Patient Preference and Adherence.<\/em><\/li>\n \t
            4. \u00a0A case study of polypharmacy management in nine European countries: Implications for change management and implementation.<\/strong><\/a> PLoS ONE.<\/em><\/li>\n \t
            5. Persistence with statins in primary prevention of cardiovascular disease: findings from a cohort of Spanish workers.<\/strong><\/a> Revista Espanola de Cardiologia.<\/em><\/li>\n \t
            6. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence.<\/a><\/strong> Clinical and Translational Allergy.<\/em><\/li>\n \t
            7. Did the new Italian law on mandatory vaccines affect adverse event Following immunization\u2019s reporting? A pharmacovigilance study in Southern Italy.<\/strong><\/a> Frontiers in Pharmacology.<\/em><\/li>\n \t
            8. Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study.<\/strong><\/a> Allergy: European Journal of Allergy and Clinical Immunology.<\/em><\/li>\n \t
            9. Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study.<\/strong><\/a> Allergy: European Journal of Allergy and Clinical Immunology<\/em>.<\/li>\n \t
            10. Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe.<\/strong><\/a> Archives of Gerontology and Geriatrics. <\/em><\/li>\n \t
            11. Geolocation with respect to personal privacy for the Allergy Diary app – A MASK study.<\/strong><\/a> World Allergy Organization Journal.<\/em><\/li>\n \t
            12. The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study.<\/strong><\/a> Allergy: European Journal of Allergy and Clinical Immunology. <\/em><\/li>\n \t
            13. Prevalence of antibiotic prescription in southern Italian outpatients: Real-world data analysis of socioeconomic and sociodemographic variables at a municipality level.<\/strong><\/a> ClinicoEconomics and Outcomes Research.<\/em><\/li>\n \t
            14. The work productivity and activity impairment allergic specific (WPAI-AS) questionnaire using mobile technology: The mask study.<\/strong><\/a> Journal of Investigational Allergology and Clinical Immunology.<\/em><\/li>\n \t
            15. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) – EIP on AHA Twinning Reference Site (GARD research demonstration project).<\/strong><\/a> Allergy: European Journal of Allergy and Clinical Immunology. <\/em><\/li>\n<\/ol><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
              \n\t\t\t\t\t
              \n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t2017<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
                \n \t
              1. Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control.<\/strong><\/a> Clinical and Experimental Allergy.<\/em><\/li>\n \t
              2. Differences in drug use between men and women: An Italian cross-sectional study.<\/strong><\/a> BMC Women\u2019s Health.<\/em><\/li>\n \t
              3. Different approaches to the assessment of adherence and persistence with cardiovascular-disease preventive medications.<\/strong><\/a> Current Medical Research and Opinion. <\/em><\/li>\n \t
              4. Biological therapy utilization, switching, and cost among patients with psoriasis: Retrospective analysis of administrative databases in southern Italy.<\/strong><\/a> ClinicoEconomics and Outcomes Research.<\/em><\/li>\n \t
              5. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: A SUNFRAIL report.<\/strong><\/a> Clinical and Translational Allergy<\/em>.<\/li>\n \t
              6. The Italian reference sites of the European innovation partnership on active and healthy ageing: Progetto Mattone Internazionale as an enabling factor.<\/strong><\/a> Annali dell\u2019Istituto Superiore di Sanit\u00e0. <\/em><\/li>\n \t
              7. Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA.<\/strong><\/a> Journal of Nutrition, Health and Aging.<\/em><\/li>\n \t
              8. Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting.<\/strong><\/a> Pharmacological Research.<\/em><\/li>\n \t
              9. Implementing an ICT-Based Polypharmacy Management Program in Italy.<\/strong><\/a> Translational medicine at UniSa.<\/em><\/li>\n \t
              10. Measuring medication adherence in health-related databases.<\/strong> Adherence to Medical Plans for Active and Healthy Ageing (NY, USA: Nova Science Publisher, Inc.).<\/em><\/li>\n \t
              11. Evidence-based directions for polypharmacy revision: The experience gained by the campania reference site in the framework of the eip-aha action group A1 and of the friendd pilot study.<\/strong> Adherence to Medical Plans for Active and Healthy Ageing (NY, USA: Nova Science Publisher, Inc.). <\/em><\/li>\n<\/ol><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
                \n\t\t\t\t\t
                \n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t2016<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
                  \n \t
                1. Rates and reasons for lack of persistence with anti-osteoporotic drugs: Analysis of the Campania region database.<\/strong><\/a> Clinical Cases in Mineral and Bone Metabolism<\/em>.<\/li>\n \t
                2. Toward appropriate criteria in medication adherence assessment in older persons: Position Paper.<\/strong><\/a> Aging Clinical and Experimental Research<\/em>.<\/li>\n \t
                3. Active and Healthy Ageing and Independent Living 2016.<\/strong><\/a> Journal of Aging Research<\/em>.<\/li>\n \t
                4. Prescription patterns of antidiabetic treatment in the elderly. Results from southern Italy.<\/strong><\/a> Current Diabetes Reviews. <\/em><\/li>\n \t
                5. Scaling up health knowledge at European level requires sharing integrated data: An approach for collection of database specification.<\/strong><\/a> ClinicoEconomics and Outcomes Research.<\/em><\/li>\n \t
                6. Italian translation and cultural adaptation of the communication assessment tool in an outpatient surgical clinic.<\/strong><\/a> BMC Health Services Research. <\/em><\/li>\n \t
                7. The Tosca Registry: An Ongoing, Observational, Multicenter Registry for Chronic Heart Failure.<\/strong><\/a> Translational medicine at UniSa<\/em>.<\/li>\n \t
                8. The European Innovation Partnership on Active and Healthy Ageing Synergies: Protocol for a Prospective Observational Study to Measure the Impact of a Community-Based Program on Prevention and Mitigation of Frailty (ICP \u2013 PMF) in Community-Dwelling Older Adults.<\/strong><\/a> Translational medicine at UniSa.<\/em><\/li>\n \t
                9. La prescrizione di antidiabetici nel paziente anziano: trend prescrittivi. Antidiabetic drugs in the elderly: prescribing trends.<\/strong><\/a> Giornale Italiano di Farmacoeconomia e Farmacoutilizzazione.<\/em><\/li>\n \t
                10. Analisi dei dati della diagnostica per immagini nella ASL Caserta. <\/strong>Rassegna Medica.<\/em><\/li>\n<\/ol><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
                  \n\t\t\t\t\t
                  \n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t2015<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
                    \n \t
                  1. Evaluation of therapeutical appropriateness in psychiatric treatment of schizophrenia, by integrating computer data records with clinical audit results [Valutazione dell\u2019appropriatezza prescrittiva in psichiatria: un progetto di clinical audit nella ASL di Caserta].<\/strong><\/a> Rivista di psichiatria.<\/em><\/li>\n \t
                  2. Effectiveness of the cardiopain initiative in reducing inappropriate nsaid prescriptions in pain therapy among high cardiovascular risk patients: An informative Italian survey.<\/strong><\/a> Heart International.<\/em><\/li>\n \t
                  3. Self-assessment of adherence to medication: A case study in Campania region community-dwelling population.<\/strong><\/a> Journal of Aging Research.<\/em><\/li>\n \t
                  4. Active and healthy ageing and independent living.<\/strong><\/a> Journal of Aging Research<\/em>.<\/li>\n \t
                  5. Low-protein diet for chronic kidney disease in the Caserta Local Health Unit: the SaniARP Initiative. <\/strong>Farmeconomia-Health economics and therapeutic pathways<\/em>.<\/li>\n \t
                  6. Proceedings of the EIP on AHA: A3 Action Group on Frailty.<\/strong><\/a> Translational medicine at UniSa<\/em>.<\/li>\n \t
                  7. Economic evaluation of screening programs for hepatitis C virus infection: Evidence from literature.<\/strong><\/a> Risk Management Healthcare Policy. <\/em><\/li>\n \t
                  8. Investigating the generalizability of economic evaluations conducted in Italy: a critical review.<\/strong><\/a> Value in Health.<\/em><\/li>\n \t
                  9. How healthy is community-dwelling elderly population? Results from Southern Italy.<\/strong><\/a> Translational medicine at UniSa. <\/em><\/li>\n \t
                  10. Interventional tools to improve medication adherence: Review of literature.<\/strong><\/a> Patient Preference and Adherence<\/em>.<\/li>\n \t
                  11. Doctors commitment and long-term effectiveness for cost containment policies: Lesson learned from biosimilar drugs.<\/strong><\/a> ClinicoEconomics and Outcomes Research. <\/em><\/li>\n<\/ol><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
                    \n\t\t\t\t\t
                    \n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t2014<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
                      \n \t
                    1. Lower incidence of macrovascular complications inpatients on insulin glargine versus those on basal human insulins: A population-based cohort study in Italy.<\/strong> Nutrition, Metabolism and Cardiovascular Diseases.<\/em><\/li>\n \t
                    2. Assessment and potential determinants of compliance and persistence to antiosteoporosis therapy in Italy.<\/strong><\/a> American Journal of Managed Care. <\/em><\/li>\n<\/ol><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
                      \n\t\t\t\t\t
                      \n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t2013<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
                        \n \t
                      1. Lower rate of cardiovascular complications in patients on bolus insulin analogues: A retrospective population-based cohort study.<\/strong><\/a> PloS one. <\/em><\/li>\n \t
                      2. Osteoporosis drugs in real-world clinical practice: An analysis of persistence.<\/strong><\/a> Aging Clinical and Experimental Research.<\/em><\/li>\n<\/ol><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
                        \n\t\t\t\t\t
                        \n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t2012<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
                          \n \t
                        1. Proton pump inhibitors prescribing following the introduction of generic drugs.<\/strong><\/a> European Journal of Clinical Investigation. <\/em><\/li>\n \t
                        2. The burden of hospitalization related to diabetes mellitus: A population-based study.<\/strong><\/a> Nutrition, Metabolism and Cardiovascular Diseases. <\/em><\/li>\n \t
                        3. Le politiche di compartecipazione alla spesa farmaceutica.<\/strong><\/a> Giornale Italiano di Farmacoeconomia e Farmacoutilizzazione.<\/em><\/li>\n \t
                        4. La prescrizione di antibiotici in Regione Campania negli anni 2002-2011.\u00a0<\/strong><\/a> Giornale Italiano di Farmacoeconomia e Farmacoutilizzazione.<\/em><\/li>\n \t
                        5. La valutazione delle politiche farmaceutiche di cost containment.<\/strong> SEEd Edizioni.<\/em><\/li>\n<\/ol><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
                          \n\t\t\t\t\t
                          \n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t2011<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
                            \n \t
                          1. Pharmaco-economic consequences of losartan therapy in patients undergoing diabetic end stage renal disease in EU and USA.<\/strong><\/a> Clinical and Experimental Hypertension.<\/em><\/li>\n \t
                          2. Valutazione economica dello studio CARDS: un aggiornamento.<\/strong><\/a> Farmacoeconomia e percorsi terapeutici.<\/em><\/li>\n \t
                          3. Valutazioni economiche di atorvastatina in prevenzione secondaria: un aggiornamento.<\/em><\/strong><\/a> Farmacoeconomia e percorsi terapeutici.<\/em><\/li>\n<\/ol><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
                            \n\t\t\t\t\t
                            \n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t2010<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
                              \n \t
                            1. Cost\/effectiveness analysis of atorvastatin in patients with acute coronary syndromes. Farmeconomia.<\/strong> Health economics and therapeutic pathways.<\/em><\/li>\n<\/ol><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
                              \n\t\t\t\t\t
                              \n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t2009<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
                                \n \t
                              1. Emerging role of capecitabine in gastric cancer. <\/strong>Pharmacotherapy<\/em>.<\/li>\n \t
                              2. L\u2019utilizzo dei database amministrativi per la ricercar di base e la programmazione sanitaria: l\u2019esperienza dell\u2019ASL Salerno 2.<\/strong><\/a> Giornale Italiano di Farmacoeconomia e Farmacoutilizzazione.<\/em><\/li>\n \t
                              3. Attivit\u00e0 di monitoraggio delle prescrizioni farmaceutiche: la collaborazione tra il settore farmaceutico della Regione Campania e il Centro di Ricerca in Farmacoeconomia e Farmacoutilizzazione (CIRFF).<\/strong><\/a> Care.<\/em><\/li>\n \t
                              4. Influenza dei farmaci generici sulle dinamiche prescrittive degli inibitori di pompa protonica in medicina generale.<\/em><\/strong><\/a> Farmacoeconomia e percorsi terapeutici.<\/em><\/li>\n<\/ol><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
                                \n\t\t\t\t\t
                                \n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t2008<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
                                  \n \t
                                1. Aspetti epidemiologici ed economici del diabete in Campania: analisi dei dati di prescrizione attraverso farmaci traccianti.<\/strong><\/a> Farmcoeconomia e percorsi terapeutici.<\/em><\/li>\n \t
                                2. Valutazione economica dello studio IDEAL.<\/strong><\/a> Farmacoeconomia e percorsi terapeutici.<\/em><\/li>\n \t
                                3. Appropriatezza prescrittiva e politiche sanitarie.<\/strong><\/a> Care.<\/em><\/li>\n \t
                                4. \u00a0Valutazione dell\u2019utilizzo di antibiotici iniettabili nella Regione Campania.<\/strong><\/a> Farmacoeconomia e percorsi terapeutici.<\/em><\/li>\n<\/ol><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
                                  \n\t\t\t\t\t
                                  \n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t2007<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
                                    \n \t
                                  1. Valutazione economica dello studio IDEAL.<\/strong><\/a> Farmacoeconomia e percorsi terapeutici<\/em>.<\/li>\n \t
                                  2. Valutazione economica dello studio AVERT. <\/strong><\/a>\u00a0<\/strong>Farmeconomia e percorsi terapeutici.<\/em><\/li>\n \t
                                  3. Valutazione economica dello studio CARDS.<\/strong><\/a> Farmacoeconomia e percorsi terapeutici. <\/em><\/li>\n<\/ol><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
                                    \n\t\t\t\t\t
                                    \n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t2006<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
                                      \n \t
                                    1. Pharmacoeconomic consequences of amlodipine besylate therapy in patients undergoing PTCA.<\/strong><\/a> Pharmacological research. <\/em><\/li>\n \t
                                    2. The pharmacoeconomic impact of amlodipine use on coronary artery disease.<\/strong><\/a> Pharmacological Research. <\/em><\/li>\n<\/ol><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t
                                      \n\t\t\t\t\t
                                      \n\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t2005<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t
                                        \n \t
                                      1. Cost-effectiveness analysis of b isoprolol treatment for heart failure. <\/strong>Italian Heart Journal. <\/em><\/li>\n<\/ol><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
                                        \n\t\t\t\t\t\t
                                        \n\t\t\t\t\t\t\t
                                        \n\t\t\t\t\t
                                        \n\t\t\t
                                        \n\t\t\t\t\t\t\t
                                        \n\t\t\t\t\t\t
                                        \n\t\t\t\t
                                        \n\t\t\t\t\t
                                        \n\t\t\t
                                        <\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

                                        Articoli Scientifici 2023 Drug Utilization and Measurament of Medication Adherence: A Real World Study of Psoriasis in Italy. Pharmaceutics Longitudinal Trajectory Modeling to Assess Adherence to Sacubitril\/Valsartan among Patients with Heart Failure. Pharmaceutics Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA.\u00a0Journal of Nutrition, Health and Aging […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":[],"yoast_head":"\nArticoli Scientifici - CIRFF<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cirff.it\/?page_id=17437\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Articoli Scientifici - CIRFF\" \/>\n<meta property=\"og:description\" content=\"Articoli Scientifici 2023 Drug Utilization and Measurament of Medication Adherence: A Real World Study of Psoriasis in Italy. Pharmaceutics Longitudinal Trajectory Modeling to Assess Adherence to Sacubitril\/Valsartan among Patients with Heart Failure. Pharmaceutics Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA.\u00a0Journal of Nutrition, Health and Aging […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cirff.it\/?page_id=17437\" \/>\n<meta property=\"og:site_name\" content=\"CIRFF\" \/>\n<meta property=\"article:modified_time\" content=\"2023-12-20T15:40:33+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tempo di lettura stimato\">\n\t<meta name=\"twitter:data1\" content=\"12 minuti\">\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cirff.it\/#website\",\"url\":\"https:\/\/www.cirff.it\/\",\"name\":\"CIRFF\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":\"https:\/\/www.cirff.it\/?s={search_term_string}\",\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cirff.it\/?page_id=17437#webpage\",\"url\":\"https:\/\/www.cirff.it\/?page_id=17437\",\"name\":\"Articoli Scientifici - CIRFF\",\"isPartOf\":{\"@id\":\"https:\/\/www.cirff.it\/#website\"},\"datePublished\":\"2023-12-11T13:37:36+00:00\",\"dateModified\":\"2023-12-20T15:40:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cirff.it\/?page_id=17437#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cirff.it\/?page_id=17437\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cirff.it\/?page_id=17437#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"item\":{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cirff.it\/\",\"url\":\"https:\/\/www.cirff.it\/\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"position\":2,\"item\":{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cirff.it\/?page_id=17437\",\"url\":\"https:\/\/www.cirff.it\/?page_id=17437\",\"name\":\"Articoli Scientifici\"}}]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","_links":{"self":[{"href":"https:\/\/www.cirff.it\/index.php?rest_route=\/wp\/v2\/pages\/17437"}],"collection":[{"href":"https:\/\/www.cirff.it\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.cirff.it\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.cirff.it\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cirff.it\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=17437"}],"version-history":[{"count":48,"href":"https:\/\/www.cirff.it\/index.php?rest_route=\/wp\/v2\/pages\/17437\/revisions"}],"predecessor-version":[{"id":17754,"href":"https:\/\/www.cirff.it\/index.php?rest_route=\/wp\/v2\/pages\/17437\/revisions\/17754"}],"wp:attachment":[{"href":"https:\/\/www.cirff.it\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=17437"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}